| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |